ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR.

Hervé Avet-Loiseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.